当前位置:首页 - 行情中心 - 心脉医疗(688016) - 财务分析 - 现金流量表

心脉医疗

(688016)

  

流通市值:104.79亿  总市值:104.79亿
流通股本:1.23亿   总股本:1.23亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金792,952,089.86245,121,060.341,369,647,675.84854,974,998.51
  收到的税费返还--501,911.56999,420.29
  收到其他与经营活动有关的现金26,006,952.232,343,741.5884,787,483.59105,822,276.4
  经营活动现金流入小计818,959,042.09247,464,801.921,454,937,070.99961,796,695.2
  购买商品、接受劳务支付的现金178,518,855.6974,389,722.11284,442,393.51143,784,792.11
  支付给职工以及为职工支付的现金149,109,224.4277,022,849.17283,610,959.65202,134,285.92
  支付的各项税费118,160,642.0142,619,371.92178,954,504.5151,959,022.89
  支付其他与经营活动有关的现金83,584,121.0242,750,736.63134,865,258.08100,716,945.92
  经营活动现金流出小计529,372,843.14236,782,679.83881,873,115.74598,595,046.84
  经营活动产生的现金流量净额289,586,198.9510,682,122.09573,063,955.25363,201,648.36
二、投资活动产生的现金流量:
  收回投资收到的现金2,029,000,000750,000,0004,930,000,0002,925,000,000
  取得投资收益收到的现金4,961,936.611,211,896.1215,976,849.839,168,253.08
  处置固定资产、无形资产和其他长期资产收回的现金净额447,463.2618,000--
  投资活动现金流入小计2,034,409,399.87751,229,896.124,945,976,849.832,934,168,253.08
  购建固定资产、无形资产和其他长期资产支付的现金79,613,328.129,152,851.47303,033,026.27215,020,875.92
  投资支付的现金2,834,000,0001,640,000,0005,030,000,0004,090,000,000
  投资活动现金流出小计2,913,613,328.11,669,152,851.475,333,033,026.274,305,020,875.92
  投资活动产生的现金流量净额-879,203,928.23-917,922,955.35-387,056,176.44-1,370,852,622.84
三、筹资活动产生的现金流量:
  取得借款收到的现金--126,000,000126,000,000
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--126,000,000126,000,000
  偿还债务支付的现金--140,000,000140,000,000
  分配股利、利润或偿付利息支付的现金120,841,074-201,834,960.143,558,034.8
  支付其他与筹资活动有关的现金6,068,898.013,051,198.59134,083,628.72122,755,433.44
  筹资活动现金流出小计126,909,972.013,051,198.59475,918,588.82306,313,468.24
  筹资活动产生的现金流量净额-126,909,972.01-3,051,198.59-349,918,588.82-180,313,468.24
四、汇率变动对现金及现金等价物的影响-7,310,594.89-3,946,951.74-2,871,180.32255,712.02
五、现金及现金等价物净增加额-723,838,296.18-914,238,983.59-166,781,990.33-1,187,708,730.7
  加:期初现金及现金等价物余额1,892,049,254.811,892,049,254.812,058,831,245.142,058,831,245.14
  期末现金及现金等价物余额1,168,210,958.63977,810,271.221,892,049,254.81871,122,514.44
补充资料:
  净利润317,518,865.36-554,659,959.66-
  资产减值准备5,908,932.54-9,271,248.76-
  固定资产和投资性房地产折旧4,877,581.79-13,593,988.86-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧4,877,581.79-13,593,988.86-
  无形资产摊销27,397,791.96-53,408,929.34-
  长期待摊费用摊销4,665,177.09-10,651,037.81-
  处置固定资产、无形资产和其他长期资产的损失70,970.84---
  固定资产报废损失--89,021-
  公允价值变动损失---367,945.21-
  财务费用6,718,580.51-6,882,102.44-
  投资损失-6,428,344.82--15,976,849.83-
  递延所得税-10,770,541.51--11,348,913.81-
  其中:递延所得税资产减少-6,905,308.88--5,372,460.42-
    递延所得税负债增加-3,865,232.63--5,976,453.39-
  存货的减少-39,896,645.93--14,369,865.11-
  经营性应收项目的减少-93,563,064.79-90,927,824.01-
  经营性应付项目的增加57,024,099.42--159,007,774.59-
  其他6,420,739.12-14,287,357.8-
  不涉及现金收支的投资和筹资活动金额其他项目--1,220,071.08-
  现金的期末余额1,168,210,958.63-1,892,049,254.81-
  减:现金的期初余额1,892,049,254.81-2,058,831,245.14-
  现金及现金等价物的净增加额-723,838,296.18--166,781,990.33-
公告日期2026-08-272026-04-302026-03-312025-10-30
审计意见(境内)标准无保留意见
TOP↑